Indivior Pharmaceuticals, Inc. - 8-K Filing
Indivior reports Q2 revenue of $343M, raises full-year guidance and announces merger with Supernus (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $INDV